Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 18;6:86. doi: 10.1038/s41541-021-00348-x

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — a Representative dot plots of freshly digested parental pMOC1 or MOC1-E6 tumors obtained from mice treated with PRGN-2012 or empty GC46 assessed for T-lymphocyte accumulation via flow cytometry. Normalized quantification is shown on the right. b Representative H&E and immunofluorescence photomicrographs demonstrating localization of T lymphocytes within MOC1-E6 tumors treated with PRGN-2012 or empty GC46. c Quantification of total T lymphocytes per high power field (HPF). mpIF multiplex immunofluorescence. d Quantification of tumor margin vs tumor parenchyma localization of CD8+ and CD4+ T lymphocytes.